Stephen Elledge's Har­vard lab takes $17M to birth Im­muneID, a high-through­put an­ti­body start­up

Lea Hachi­gian, a prin­ci­pal at the Long­wood Fund, re­calls work­ing with Har­vard pro­fes­sor Stephen Elledge three years ago on the launch of TCR-fo­cused TScan Ther­a­peu­tics. Elledge ini­tial­ly set out to screen anti­gen-TCR match­es in a faster, more sys­tem­at­ic way and spent sev­en years putting to­geth­er the tech for a plat­form that could run mul­ti­ple T cell re­cep­tors against anti­gen epi­topes and pin­point the ex­act pairs that ap­pear to in­ter­act.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN